Published in EMBO Mol Med on February 01, 2010
Myelination and support of axonal integrity by glia. Nature (2010) 3.54
Oligodendroglia: metabolic supporters of axons. Trends Cell Biol (2013) 1.15
Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nat Med (2012) 0.98
The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation. Front Pharmacol (2012) 0.96
Targeted ablation of oligodendrocytes triggers axonal damage. PLoS One (2011) 0.93
Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination. J Neurosci (2013) 0.92
Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease. J Anat (2011) 0.84
Demyelination as a rational therapeutic target for ischemic or traumatic brain injury. Exp Neurol (2015) 0.84
Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain. ASN Neuro (2010) 0.84
Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis. Neuropharmacology (2015) 0.83
Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model. Am J Hum Genet (2014) 0.81
Neuroinflammation by cytotoxic T-lymphocytes impairs retrograde axonal transport in an oligodendrocyte mutant mouse. PLoS One (2012) 0.81
Clinically relevant intronic splicing enhancer mutation in myelin proteolipid protein leads to progressive microglia and astrocyte activation in white and gray matter regions of the brain. J Neuroinflammation (2013) 0.80
Focal axonal swellings and associated ultrastructural changes attenuate conduction velocity in central nervous system axons: a computer modeling study. Physiol Rep (2013) 0.77
Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease. Ann Clin Transl Neurol (2015) 0.76
Axonal transection in the lesions of multiple sclerosis. N Engl J Med (1998) 12.21
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet (2003) 5.43
Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci (2008) 5.15
Axonal damage in acute multiple sclerosis lesions. Brain (1997) 3.88
The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain (2009) 3.84
Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci (2008) 3.82
Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 3.58
Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell (1992) 2.80
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci (2003) 2.17
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain (2007) 1.94
Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med (2007) 1.77
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71
Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol (2004) 1.62
Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron (1994) 1.50
Myelin acquisition in the central nervous system of the mouse revealed by an MBP-Lac Z transgene. J Neurosci (1992) 1.49
Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. J Cell Biol (2000) 1.43
Glycogen regulation and functional role in mouse white matter. J Physiol (2003) 1.41
How the optic nerve allocates space, energy capacity, and information. J Neurosci (2009) 1.34
Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain (2008) 1.26
Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia (2009) 1.25
Functions of optic nerve glia: axoglial signalling in physiology and pathology. Eye (Lond) (2004) 1.17
Unloading kinesin transported cargoes from the tubulin track via the inflammatory c-Jun N-terminal kinase pathway. FASEB J (2006) 1.14
The role of CNS glia in preserving axon function. Curr Opin Neurobiol (2009) 1.12
Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature (1992) 1.10
Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol (2006) 1.07
Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp Neurol (2005) 1.06
Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol (2006) 1.05
Mice with altered myelin proteolipid protein gene expression display cognitive deficits accompanied by abnormal neuron-glia interactions and decreased conduction velocities. J Neurosci (2009) 1.03
Shaking pups: a disorder of central myelination in the spaniel dog. II. Ultrastructural observations on the white matter of the cervical spinal cord. J Neurocytol (1981) 1.03
Changes in microtubule stability and density in myelin-deficient shiverer mouse CNS axons. J Neurosci (2001) 1.01
Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiol Dis (2006) 1.01
Tract-tracing in the nervous system of vertebrates using horseradish peroxidase and its conjugates: tracers, chromogens and stabilization for light and electron microscopy. Brain Res Brain Res Protoc (1997) 0.96
Axon loss in multiple sclerosis. Lancet (1998) 0.92
Distinct phenotypes associated with increasing dosage of the PLP gene: implications for CMT1A due to PMP22 gene duplication. Ann N Y Acad Sci (1999) 0.91
Genetic background determines phenotypic severity of the Plp rumpshaker mutation. J Neurosci Res (2003) 0.89
Fructose supports energy metabolism of some, but not all, axons in adult mouse optic nerve. J Neurophysiol (2005) 0.81
Effects of K+ channel blockers on the anoxic response of CNS myelinated axons. Neuroreport (1998) 0.80
Axonal neuregulin-1 regulates myelin sheath thickness. Science (2004) 6.09
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet (2003) 5.43
Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci (2008) 5.15
The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron (2006) 4.12
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature (2012) 3.09
Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74
Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol (2013) 2.61
Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice. Genesis (2006) 2.52
Neurod1 is essential for the survival and maturation of adult-born neurons. Nat Neurosci (2009) 2.38
High cholesterol level is essential for myelin membrane growth. Nat Neurosci (2005) 2.34
Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet (2007) 2.30
Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J Neurosci (2005) 2.27
Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci (2010) 2.25
Monitoring regulated protein-protein interactions using split TEV. Nat Methods (2006) 2.24
Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med (2003) 2.17
Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. J Cell Biol (2009) 1.97
Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J Neurosci (2010) 1.93
Pancreatic beta cells require NeuroD to achieve and maintain functional maturity. Cell Metab (2010) 1.88
Pyramidal neurons of upper cortical layers generated by NEX-positive progenitor cells in the subventricular zone. Proc Natl Acad Sci U S A (2005) 1.77
Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development. J Cell Biol (2007) 1.69
Notch1 control of oligodendrocyte differentiation in the spinal cord. J Cell Biol (2002) 1.65
Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science (2011) 1.64
Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol (2004) 1.62
Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons? Proteomics Clin Appl (2007) 1.58
Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci (2007) 1.58
Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite development. Neuron (2010) 1.57
Global transcriptome analysis of genetically identified neurons in the adult cortex. J Neurosci (2006) 1.55
Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors. Nat Neurosci (2009) 1.54
Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites. J Cell Biol (2006) 1.49
A role for Schwann cell-derived neuregulin-1 in remyelination. Nat Neurosci (2012) 1.47
Beta1 integrins in radial glia but not in migrating neurons are essential for the formation of cell layers in the cerebral cortex. J Neurosci (2007) 1.45
Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia (2008) 1.45
FAK is required for axonal sorting by Schwann cells. J Cell Biol (2007) 1.43
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain (2007) 1.42
Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination. Mol Cell Biol (2004) 1.40
Arrest of myelination and reduced axon growth when Schwann cells lack mTOR. J Neurosci (2012) 1.39
Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J Neurosci Res (2005) 1.39
Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum Mol Genet (2003) 1.32
Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J Lipid Res (2010) 1.31
Disturbed clockwork resetting in Sharp-1 and Sharp-2 single and double mutant mice. PLoS One (2008) 1.28
Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol (2002) 1.27
Calcium activation of the LMO4 transcription complex and its role in the patterning of thalamocortical connections. J Neurosci (2006) 1.27
Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci (2011) 1.26
Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol (2006) 1.25
Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia (2009) 1.25
Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity. Cell Metab (2011) 1.25
CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia (2005) 1.22
Cdc42 and Rac1 signaling are both required for and act synergistically in the correct formation of myelin sheaths in the CNS. J Neurosci (2006) 1.22
Hippocampal cGMP-dependent protein kinase I supports an age- and protein synthesis-dependent component of long-term potentiation but is not essential for spatial reference and contextual memory. J Neurosci (2003) 1.20
Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J Neurosci (2006) 1.20
A transcriptional network coordinately determines transmitter and peptidergic fate in the dorsal spinal cord. Dev Biol (2008) 1.19
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Ann Neurol (2007) 1.18
Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness. J Neurosci (2012) 1.17
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. EMBO Mol Med (2012) 1.17
The role of myelin and oligodendrocytes in axonal energy metabolism. Curr Opin Neurobiol (2013) 1.17
Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry (2010) 1.17
Beta1-integrin signaling mediates premyelinating oligodendrocyte survival but is not required for CNS myelination and remyelination. J Neurosci (2006) 1.16
Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function. Dev Neurosci (2006) 1.15
A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease. Proc Natl Acad Sci U S A (2007) 1.12
NG2-expressing cells in the nervous system revealed by the NG2-EYFP-knockin mouse. Genesis (2008) 1.12
The role of CNS glia in preserving axon function. Curr Opin Neurobiol (2009) 1.12
Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J Neurosci (2009) 1.12
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics (2009) 1.10
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry (2010) 1.10
Sox10-rtTA mouse line for tetracycline-inducible expression of transgenes in neural crest cells and oligodendrocytes. Genesis (2004) 1.09
Cre/loxP-mediated inactivation of the bHLH transcription factor gene NeuroD/BETA2. Genesis (2005) 1.08
SHARP1/DEC2 inhibits adipogenic differentiation by regulating the activity of C/EBP. EMBO Rep (2008) 1.08
Early neuronal and glial fate restriction of embryonic neural stem cells. J Neurosci (2008) 1.07
Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles. EMBO J (2013) 1.06
Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia. J Neurosci (2006) 1.05
Phylogeny of proteolipid proteins: divergence, constraints, and the evolution of novel functions in myelination and neuroprotection. Neuron Glia Biol (2009) 1.04
Misalignment of PLP/DM20 transmembrane domains determines protein misfolding in Pelizaeus-Merzbacher disease. J Neurosci (2011) 1.04
Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia (2011) 1.04
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res (2006) 1.04
Murine spinal cord explants: a model for evaluating axonal growth and myelination in vitro. J Neurosci Res (2006) 1.03
A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A (2005) 1.03
Animal models of inherited neuropathies. Curr Opin Neurol (2006) 1.02
Evolution of myelin proteolipid proteins: gene duplication in teleosts and expression pattern divergence. Mol Cell Neurosci (2005) 1.01
Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiol Dis (2006) 1.01
The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat. Psychopharmacology (Berl) (2010) 1.01
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. EMBO Mol Med (2011) 1.00
Subtle myelin defects in PLP-null mice. Glia (2006) 1.00
Monte Carlo simulation of parameter confidence intervals for non-linear regression analysis of biological data using Microsoft Excel. Comput Methods Programs Biomed (2011) 1.00
PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease. Glia (2007) 0.99
Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nat Med (2012) 0.98
Phosphatidylinositol 4,5-bisphosphate-dependent interaction of myelin basic protein with the plasma membrane in oligodendroglial cells and its rapid perturbation by elevated calcium. J Neurosci (2009) 0.97
A critical role for the cholesterol-associated proteolipids PLP and M6B in myelination of the central nervous system. Glia (2013) 0.97